Skip to content

Clinical Utility of Neuromodulation on Tinnitus

Clinical Utility of Neuromodulation on Tinnitus: A Systematic Review

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05674435
Enrollment
26
Registered
2023-01-06
Start date
2022-01-01
Completion date
2022-09-30
Last updated
2023-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Brief summary

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Interventions

None listed

Sponsors

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Tinnitus patients * At least one of the neurofeedback methods * Single and multi-center * Randomized control trials and observational studies

Exclusion criteria

* Non-peer-reviewed papers, letters, editorials * Not English language

Design outcomes

Primary

MeasureTime frame
Tinnitus severity scores9 months

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026